Literature DB >> 19326979

Evaluation of the new HydroSoft coil in a canine model of bifurcation aneurysm. Laboratory investigation.

Tomoyuki Tsumoto1, Yasunari Niimi, Alejandro Berenstein.   

Abstract

OBJECT: The present study was designed to evaluate the new HydroSoft coil as a finishing coil in a canine model of a wide-necked, high-flow bifurcation aneurysm.
METHODS: Nine experimental aneurysms were created. The aneurysm dome was first embolized with bare platinum coils and HydroCoils, and then the remaining neck portion was embolized with HydroSoft coils to obtain maximum aneurysm occlusion. Follow-up angiography was performed at 1 and 3 months, and histopathological analysis was performed after the 3-month follow-up angiography.
RESULTS: One hundred twenty-five HydroSoft coils were deployed into 9 aneurysms without any technical problem. The mean volume % of the bare platinum coils, HydroCoils, and HydroSoft coils were 23.0+/-15.9, 63.0+/-23.5, and 13.9+/-8.9%, respectively. The mean aneurysm volumetric occlusion rate was 45.9%. At the 3-month follow-up angiography, 8 of 9 aneurysms remained stable and had not recanalized. Microscopically, most aneurysms showed complete endothelialization and thick neointima formation at the neck surface with no thrombus present.
CONCLUSIONS: The HydroSoft coil appears feasible as a finishing coil based on the results of this animal study. HydroSoft coils inserted at the neck of the aneurysm may help induce neointima formation, which may lead to less coil compaction and aneurysm recanalization in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326979     DOI: 10.3171/2008.10.JNS08855

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  GREAT-a randomized aneurysm trial. Design of a randomized controlled multicenter study comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment.

Authors:  Christian Taschner; René Chapot; Vincent Costalat; Patrick Courthéoux; Xavier Barreau; Jerome Berge; Laurent Pierot; Kryzsztof Kadziolka; Betty Jean; Raphael Blanc; Alessandra Biondi; Hervé Brunel; Sophie Gallas; Ansgar Berlis; Denis Herbreteau; Joachim Berkefeld; Christoph Groden; Horst Urbach; Samer El Shikh; Erika Graf; Alain Bonafé
Journal:  Neuroradiology       Date:  2015-02-28       Impact factor: 2.804

2.  Embolization of intracranial aneurysms with HydroSoft coils: results of the Korean multicenter study.

Authors:  J H Park; H-S Kang; M H Han; P Jeon; D-S Yoo; T H Lee
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

3.  New generation Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): a study protocol for a multicenter randomized controlled trial.

Authors:  Karl R Abi-Aad; Rami James N Aoun; Rudy J Rahme; Jennifer D Ward; Jason Kniss; Mary Jeanne Kwasny; Mithun G Sattur; Matthew E Welz; Bernard R Bendok
Journal:  Neuroradiology       Date:  2018-08-17       Impact factor: 2.804

4.  GREAT-a randomized controlled trial comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment: procedural safety and core-lab-assessedangiographic results.

Authors:  Christian A Taschner; René Chapot; Vincent Costalat; Paolo Machi; Patrick Courthéoux; Xavier Barreau; Jérôme Berge; Laurent Pierot; Kryzsztof Kadziolka; Betty Jean; Raphaël Blanc; Alessandra Biondi; Hervé Brunel; Sophie Gallas; Ansgar Berlis; Denis Herbreteau; Joachim Berkefeld; Horst Urbach; Samer El Shikh; Jens Fiehler; Hubert Desal; Erika Graf; Alain Bonafé
Journal:  Neuroradiology       Date:  2016-04-30       Impact factor: 2.804

5.  Histological and Transmission Electron Microscopy Results after Embolization with HydroSoft/HydroFrame Coils in Experimental Swine Aneurysm.

Authors:  Seisuke Iseki; Yumiko Mitome-Mishima; Ikuko Ogino; Yasuo Suga; Kenji Yatomi; Senshu Nonaka; Nobukazu Miyamoto; Akihide Kondo; Munetaka Yamamoto; Hajime Arai; Hidenori Oishi
Journal:  Biomed Res Int       Date:  2019-12-05       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.